West Pharmaceutical Services (WST) said Thursday that Chief Financial Officer Bernard Birkett plans to retire later this year and that a search for his successor is underway.
Birkett is expected to remain in the CFO role until a successor is appointed and will then serve as an advisor to support a smooth transition, the company said.
West also said it appointed Shane Campbell as chief proprietary segment officer, starting May 5. Campbell most recently served as chief commercial officer of the construction materials business at Carlisle (CSL).
Shares of West Pharmaceutical Services were down 3.5% in recent trading.
Price: 210.50, Change: -7.68, Percent Change: -3.52
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。